Neurocrine Biosciences, Inc. (NBIX) quarterly cash flow statement — complete operating, investing & financing history
Neurocrine Biosciences, Inc. (NBIX) cash flow statement — 30-year operating, investing & financing cash flows
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | 395.2M | 136.4M | 145.8M | 388.4M | 227.5M | 102M | 64.8M | 242.5M | 158M | 64.6M | 130.3M | 123.5M | 212M | 179.6M | -125.2M | 143M | 98.8M | 138.1M | -40.5M | 4.2M |
| Operating CF Margin % | 35.2% | 14.22% | 17.9% | 48.22% | 28.62% | 14.84% | 11.32% | 38.63% | 25.4% | 10.95% | 25.29% | 23.97% | 42.5% | 39.67% | -29.78% | 34.71% | 25.47% | 36.52% | -13.04% | 1.35% |
| Operating CF Growth % | 73.71% | 33.73% | 125% | 60.16% | 43.99% | 57.89% | -50.27% | 96.36% | -25.47% | -64.03% | 204.07% | -13.64% | 114.57% | 30.05% | -209.14% | 3304.76% | 59.87% | 33.82% | -146.39% | -95.28% |
| Net Income | 206.5M | 144.4M | 197.9M | 153.7M | 209.5M | 107.5M | 7.9M | 103.1M | 129.8M | 65M | 43.4M | 147.7M | 83.1M | 95.5M | -76.6M | 89M | 68.5M | -16.9M | 13.9M | -7.3M |
| Depreciation & Amortization | 44M | 24.8M | 7.3M | 7.5M | 7.7M | 7.3M | 7.6M | 7.1M | 6.5M | 7.3M | 6.2M | 5.7M | 5.5M | 5.1M | 5M | 4.4M | 4M | 3.9M | 3.3M | 3M |
| Stock-Based Compensation | 54.3M | 65M | 57.2M | 58.6M | 53.7M | 52.8M | 52.8M | 66.4M | 41.5M | 43.1M | 44.5M | 38.1M | 47.8M | 68.5M | 39.9M | 43.5M | 43.1M | 49.5M | 37M | 35.6M |
| Deferred Taxes | 10.6M | -25.3M | -61.1M | 48.2M | 168.3M | -37.4M | -13.7M | -31.3M | -34.9M | -41.3M | -15.6M | 20.6M | -4.2M | -41.5M | -31.6M | 13.5M | 9M | -3.1M | -300K | -4.7M |
| Other Non-Cash Items | 59.9M | 7.6M | -52.5M | 1.2M | -26.5M | 10.9M | 33.9M | 2.9M | 10.7M | 76.8M | 83.4M | -34.9M | 33.8M | -41.4M | -4.4M | -5.9M | -10.2M | 79.3M | -18.7M | -27.3M |
| Working Capital Changes | 19.9M | -80.1M | -3M | 119.2M | -185.2M | -39.1M | -23.7M | 94.3M | 4.4M | -86.3M | -31.6M | -53.7M | 46M | 93.4M | -57.5M | -1.5M | -15.6M | 25.4M | -75.7M | 4.9M |
| Change in Receivables | -70.2M | -84.3M | -81.4M | 38.4M | -132.3M | -79.7M | -36.9M | 2M | -12.9M | -17.6M | -11.3M | -21.4M | -30.4M | 4.2M | -41.7M | -46.5M | -22.2M | -15.5M | -78M | -21.7M |
| Change in Inventory | 3.3M | -6.5M | 4.3M | -3.4M | -12.3M | 2.1M | -1.7M | -11.6M | -3.3M | -5.3M | 1.1M | -900K | 2.9M | 1.6M | 1.8M | 3.9M | -7.7M | -300K | 1.5M | -5M |
| Change in Payables | 76.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -18.6M | -83M | 124.4M | 16.2M | 6.7M | 37.6M | 32.8M | 32.7M | 11.5M | 19.1M |
| Cash from Investing | -11.1M | -135.4M | -506.2M | -52.9M | -196.7M | -29M | 14.2M | -68.3M | 24.7M | -28.2M | -55M | -201.8M | -97.3M | -125.9M | -42.1M | -115.6M | -61.3M | 31.4M | -31.6M | 23.7M |
| Capital Expenditures | -11.6M | -7.8M | -9.1M | 2.4M | -13.2M | -12.5M | -10.7M | -7.3M | -8.1M | -11.6M | -11.2M | -5.4M | -7.6M | -6.8M | -8.5M | -1.8M | 0 | -8.8M | -7.6M | -8.9M |
| CapEx % of Revenue | 1.03% | 0.81% | 1.12% | 0.3% | 1.66% | 1.82% | 1.87% | 1.16% | 1.3% | 1.97% | 2.17% | 1.05% | 1.52% | 1.5% | 2.02% | 0.44% | 0.44% | 2.33% | 2.45% | 2.85% |
| Acquisitions | 0 | -2.36B | 63.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -42.7M | 1.7M | 0 | 0 | 0 |
| Cash from Financing | -75M | 63.4M | -86.1M | 37.3M | 45.6M | -3.3M | -117.9M | -290M | 26.4M | -293M | 69.9M | 35.4M | 18.8M | 2.9M | 8.2M | 24.6M | 11.4M | -276.4M | 6.1M | 1.8M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -279M | 0 | 0 |
| Equity Issued (Net) | -66.8M | 72.8M | -30.4M | 37.3M | 45.6M | -3.3M | -117.9M | -290M | 26.4M | 15.8M | 69.9M | 35.4M | 18.8M | 2.9M | 8.2M | 24.6M | 11.4M | 2.6M | 6.1M | 1.8M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -92.1M | -12M | -54M | 0 | 0 | -17.7M | -150M | -300M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -8.2M | -9.4M | -55.7M | 0 | 0 | 0 | 0 | 0 | 0 | -308.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 309.1M | 64.4M | -446.5M | 372.8M | 76.2M | 69.9M | -38.9M | -116.1M | 209.4M | -256.6M | 145.2M | -42.6M | 133.5M | 56.6M | -159.1M | 50.7M | 48.9M | -106.9M | -66M | 29.7M |
| Free Cash Flow | 383.6M | 128.6M | 136.7M | 390.8M | 214.3M | 89.5M | 54.1M | 235.2M | 149.9M | 53M | 119.1M | 118.1M | 204.4M | 172.8M | -133.7M | 141.2M | 100.5M | 129.3M | -48.1M | -4.7M |
| FCF Margin % | 34.17% | 13.41% | 16.78% | 48.52% | 26.96% | 13.02% | 9.45% | 37.47% | 24.1% | 8.98% | 23.11% | 22.92% | 40.98% | 38.17% | -31.8% | 34.27% | 25.91% | 34.19% | -15.49% | -1.51% |
| FCF Growth % | 79% | 43.69% | 152.68% | 66.16% | 42.96% | 68.87% | -54.58% | 99.15% | -26.66% | -69.33% | 189.08% | -16.36% | 103.38% | 33.64% | -177.96% | 3104.26% | 79.14% | 30.74% | -158.09% | -105.57% |
| FCF per Share | 3.65 | 1.23 | 1.32 | 3.81 | 2.09 | 0.89 | 0.53 | 2.29 | 1.44 | 0.51 | 1.15 | 1.15 | 2.02 | 1.72 | -1.38 | 1.40 | 1.02 | 1.35 | -0.49 | -0.05 |
| FCF Conversion (FCF/Net Income) | 1.91x | 0.94x | 0.74x | 2.53x | 1.09x | 0.95x | 8.20x | 2.35x | 1.22x | 0.99x | 3.00x | 0.84x | 2.55x | 1.88x | 1.63x | 1.61x | 1.44x | -8.17x | -2.91x | -0.58x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 2.7M | -1.6M | 0 | 1.6M | 0 | 1.9M | 0 | 1.9M | 0 | 2M | 0 | 4.6M | 0 | 4.3M |
| Taxes Paid | 23.1M | 87.9M | 300K | 7.8M | 1.1M | 71.9M | 600K | -144.5M | 51.7M | 92.6M | 200K | 46.5M | 1.6M | 3.2M | 200K | 10.1M | 1.2M | 3.1M | 0 | 1.7M |